/ Print /

Managed healthcare executive Nav

Pharmacy Strategy

Three Pricing Models That Address the High-Cost Gene, Cell Therapies
Three Pricing Models That Address the High-Cost Gene, Cell Therapies
April 15, 2018By Matthew Majewski
Here are three innovative structures in pricing models to address the high-cost of curative therapies.
How to Treat Substance Abuse with a Model of Ongoing Care
How to Treat Substance Abuse with a Model of Ongoing Care
April 13, 2018By Tracey Walker
Here's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.
The Blood Pressure Drugs that are Linked to Lower Mortality
The Blood Pressure Drugs that are Linked to Lower Mortality
April 11, 2018By Tracey Walker
A study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Top 10 AMCP Sessions Health Execs Should Attend
April 11, 2018By Aubrey Westgate
Attending the AMCP Managed Care and Specialty Pharmacy Annual Meeting in Boston April 23 to April 26? Here are our top session recommendations.
Payers Seize Opportunities to Control Diabetes Drug Costs
Payers Seize Opportunities to Control Diabetes Drug Costs
April 08, 2018By Tracey Walker
Diabetes drug spending is on the rise, but there are ways to control it.
Do Preferred Pharmacy Networks Save Money for Part D Beneficiaries?
Do Preferred Pharmacy Networks Save Money for Part D Beneficiaries?
April 02, 2018By Tracey Walker
A new Oliver Wyman reveals costly findings about Part D beneficiaries enrolled in plans without preferred pharmacy networks.
Opinion: Time to Manage ‘Clinically Superfluous’ Drug Products to Control Costs
March 29, 2018By David Calabrese RPh MHP
PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
Will PBMs Be the Next Target of Opioid Lawsuits?
March 28, 2018By Karen Appold
Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.
Global Genetic-Based Database Ramps Up
March 20, 2018By Tracey Walker
The new global DNA registry could help enable more precise treatments and identify who’s at risk for certain health problems.
Why Efforts to Curb Opioid Use Haven’t Translated to the Pediatric Population
March 19, 2018By Tracey Walker
A new study shows efforts to reduce prescription opioid use in adults has not curtailed the incidence of pediatric opioid ingestions. Find out why.